Y-mAbs Therapeutics, Inc. (YMAB)
Latest YMAB Insider Trades
About Y-mAbs Therapeutics, Inc. (YMAB)
Y-mAbs Therapeutics, Inc. files with the SEC under CIK 0001722964 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
90-Day SEC Filing Activity
No Form 4 activity for YMAB in the last 90 days.
YMAB Insider Transactions (Form 4)
11217 Form 4 filings on record, the earliest from Jun 30, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| James Healy | Other | Common Stock | 31,603 | $8.60 |
YMAB Insider Trading - FAQ
What is the latest insider trade for YMAB?
Y-mAbs Therapeutics, Inc. (YMAB) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-09-16. The full record for YMAB runs to 17 Form 4 filings, the earliest from 2025-06-30. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying YMAB stock?
No insider purchases of YMAB were filed in the last 90 days.
How many insiders are selling YMAB stock?
No insider sales of YMAB were filed in the last 90 days.
Where can I see YMAB SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks YMAB Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow YMAB insider buys?
Create a free InsiderAlpha account and press Watch on this page to add YMAB to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - James Healy view on EDGAR
- - Michael J. Rossi view on EDGAR
- - John Larocca view on EDGAR
- - Joris Wilms view on EDGAR
- - Douglas J. Gentilcore view on EDGAR
- - Thomas Gad view on EDGAR
- - David N. Gill view on EDGAR
- - Biotech Aps Wg view on EDGAR
- - Laura Hamill view on EDGAR
- - Ashu Tyagi view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where YMAB's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track YMAB insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
